Huijun Yuan,Shaoyi Chen,Matthew R. Duncan,Juan Pablo de Rivero Vaccari,Robert W. Keane,W. Dalton Dietrich,Tsung-Han Chou,Merline Benny,Augusto F. Schmidt,Karen Young,Kevin K. Park,Vittorio Porciatti,M. Elizabeth Hartnett,Shu Wu
Abstract:Retinopathy of prematurity (ROP), which often presents with bronchopulmonary dysplasia (BPD), is among the most common morbidities affecting extremely premature infants and is a leading cause of severe vision impairment in children worldwide. Activations of the inflammasome cascade and microglia have been implicated in playing a role in the development of both ROP and BPD. Apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) is pivotal in inflammasome assembly. Utilizing mouse models of both oxygen-induced retinopathy (OIR) and BPD, this study was designed to test the hypothesis that hyperoxia induces ASC speck formation, which leads to microglial activation and retinopathy, and that inhibition of ASC speck formation by a humanized monoclonal antibody, IC100, directed against ASC, will ameliorate microglial activation and abnormal retinal vascular formation.
What problem does this paper attempt to address?
The main problems that this paper attempts to solve are retinopathy of prematurity (ROP) and its related microglial cell activation and abnormal angiogenesis. Specifically, the study hypothesized that a hyperoxic environment would induce ASC speck formation, which in turn would lead to microglial cell activation and retinopathy, and tested whether inhibiting ASC speck formation by using the humanized monoclonal antibody IC100 against ASC could reduce microglial cell activation and abnormal retinal angiogenesis.
### Background and Purpose of the Paper
- **Background**: Retinopathy of prematurity (ROP) is one of the common complications in very - low - birth - weight infants and is also the main cause of severe visual impairment in children worldwide. The pathological features of ROP are divided into two stages: the first stage is the delay in vascular development, and the second stage is the formation of intraocular neovascularization. Current treatment methods include laser treatment and anti - VEGF treatment, but these methods have certain side effects.
- **Purpose**: The study aimed to explore how a hyperoxic environment (Hyperoxia) induces ASC speck formation, leading to microglial cell activation and retinopathy, and to evaluate whether the use of the humanized monoclonal antibody IC100 against ASC can effectively inhibit ASC speck formation, thereby reducing microglial cell activation and abnormal retinal angiogenesis.
### Main Methods
- **Model Establishment**:
- An oxygen - induced retinopathy (OIR) model was established using ASC - citrine reporter mice and wild - type mice (C57BL/6J).
- Mice were exposed to a normoxic environment from day 1 to day 6 after birth, to a 75% hyperoxic environment from day 7 to day 11, and then returned to a normoxic environment from day 12 to day 18.
- **Experimental Design**:
- The experimental groups included: normoxia + placebo (RA - PBS), hyperoxia + placebo (O2 - PBS), hyperoxia + IC100 intravitreal injection (O2 - IC100 - IVT), hyperoxia + IC100 intraperitoneal injection (O2 - IC100 - IP).
- ASC speck formation, vascular endothelial cell markers (IB4), microglial cell activation (AIF - 1 and CD206), and the evaluation of retinal structure and function were observed by fluorescence microscopy.
### Main Results
- **ASC Speck Formation**: Hyperoxic exposure significantly increased the formation of ASC specks, and these specks co - localized with the areas of abnormal angiogenesis.
- **Treatment Effects of IC100**:
- IC100 treatment significantly reduced vascular occlusion and intraocular neovascularization.
- IC100 treatment also reduced microglial cell activation, restored retinal structure, and improved retinal function.
- RNA sequencing results showed that IC100 treatment corrected the up - regulation of gene expression related to angiogenesis, leukocyte migration, and VEGF signaling, as well as the down - regulation of gene expression related to cell - junction assembly, neuronal processes, and neuronal recognition caused by hyperoxia.
### Conclusions
- This study demonstrated the crucial role of ASC in oxygen - induced retinopathy (OIR) and showed the effectiveness of the humanized monoclonal antibody IC100 against ASC in treating OIR mice.
- These findings suggest that IC100 may have potential application value in diseases related to hyperoxic stress and retinopathy, such as ROP.